Dr Michael E Pape

KANDO id: 1180

Bio

Fairbank is the co-founder, President, and Chairman of the Board of Nymirum, a Sigvion portfolio company. At Nymirum he manages business operations, finance, and business development, he also directs the I.T. component of the company's drug discovery platform. He is a co-founder and former director of Akebia Therapeutics. Akebia has raised over $50 million in venture funding and is currently in Phase 2 clinical trials. He actively works with the boards of other Sigvion portfolio companies. Prior to working in venture capital Fairbank spent a decade in investment banking and asset management. Mr. Fairbank received his MBA from the University of Chicago, Graduate School of Business and his bachelor's degree in Economics from Connecticut College.

Education